サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1455491

マラリアワクチンの世界市場レポート2024

Malaria Vaccines Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
マラリアワクチンの世界市場レポート2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

マラリアワクチンの市場規模は、今後数年間で急激に成長すると予想されています。 2028年には34.3%の年間複合成長率（CAGR）で153億2,000万米ドルに成長すると予想されます。 マラリアワクチン分野の予測期間における予想される成長は、撲滅目標に向けた世界の取り組み、アクセスプログラムの拡大、ワクチン普及率の増加、世界のワクチン同盟、マラリアの蔓延に対する気候変動の影響によるものと考えられます。予測期間中に予想される主な動向には、ワクチン開発における技術革新、官民パートナーシップの促進、国際協力の促進、ワクチン技術の進歩などが含まれます。これらの動向は、今後数年間でマラリアワクチンの進歩とアクセシビリティを形成し、影響を与える可能性があります。

マラリアワクチン市場は、蚊関連疾患の増加により成長すると予想されています。蚊に刺されることによって伝染するこれらの病気は、さまざまな病気を構成します。マラリアワクチン市場の主要なプレーヤーであるRTS, S/AS01（RTS, S）ワクチンは、寄生虫を認識して戦う免疫システムを訓練することにより、蚊が媒介する感染症の影響を予防および軽減するために使用されます。世界保健機関（WHO）の2023年 11月の報告書によると、2022年には世界で推定2億4,900万人のマラリア症例が発生し、前年比500万件の増加を反映しています。パキスタンでは大幅な増加が報告され、2021年の感染者数は50万人だったが、2022年には推定260万人に達しました。蚊関連疾患の発生率の増加は、マラリアワクチン市場の成長の促進剤となっています。

マラリアワクチン市場の大手企業は、小児マラリア用に設計されたワクチンなど、特定の人口統計に合わせた製品を開発することで積極的に革新を行っています。この戦略的アプローチは、より大きな顧客ベースを獲得し、売上を伸ばし、収益源を拡大することを目的としています。蚊が媒介する病気を標的とするワクチンは、蚊が媒介する病気に対する防御を提供する特殊な免疫製剤です。このカテゴリーの例は、世界中で最も致死性が高く、アフリカで蔓延しているマラリア原虫である熱帯熱マラリア原虫に対抗する小児用ワクチンです。 2022年11月、マラウイと世界保健機関（WHO）はアフリカ初の小児マラリアワクチンを導入しました。 RTSSワクチンは幼児向けに作られており、蚊が媒介する病気による死亡率を減らす可能性を示しています。有効率は30％と控えめではあるが、ガーナ、ケニア、マラウイの100万人以上の子供たちを対象としたパイロットテストを経たこのワクチンは、毎年マラリアで亡くなる40万人の命を救うという楽観的な見方を植え付けた。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界のマラリアワクチン市場、薬剤別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 熱帯熱マラリア原虫
  • 三日熱マラリア原虫
  • ハマダラカの種
  • 世界のマラリアワクチン市場、ワクチンタイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 前赤血球
  • 赤血球
  • 複数の抗原
  • その他のワクチン
  • 世界のマラリアワクチン市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 筋肉内
  • 皮下
  • 皮内
  • その他のルート
  • 世界のマラリアワクチン市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 公共
  • 民間

第7章 地域および国の分析

  • 世界のマラリアワクチン市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界のマラリアワクチン市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • マラリアワクチン市場の競合情勢
  • マラリアワクチン市場の企業プロファイル
    • Pfizer Inc.
    • Ipca Laboratories Ltd.
    • Novartis AG
    • Sanofi SA
    • GlaxoSmithKline Plc.

第31章 その他の主要および革新的な企業

  • Takeda Pharmaceutical Co Ltd.
  • Hikma Pharmaceuticals PLC
  • Amneal Pharmaceuticals LLC.
  • Lupin
  • Taj Pharmaceuticals Limited.
  • Nobelpharma Co. Ltd.
  • Bliss GVS Pharma Ltd.
  • Sanaria Inc.
  • Precigen Inc.
  • AdvaCare Pharma
  • CellFree Sciences
  • Actiza Pharmaceutical Private Limited
  • Sumaya Biotech
  • VLP Therapeutics LLC
  • GeoVax Labs Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r16492

Malaria vaccines are specialized vaccines developed to prevent malaria, a potentially life-threatening infectious disease transmitted through mosquito bites and caused by parasites belonging to the Plasmodium genus. The primary objective of these vaccines is to confer immunity against the Plasmodium parasites, offering protection against the development of malaria.

The primary types of agents involved in malaria vaccines are Plasmodium falciparum, Plasmodium vivax, and Anopheles species. Plasmodium falciparum is a protozoan parasite accountable for the most severe and deadly form of malaria in humans. Various types of malaria vaccines include pre-erythrocytic, erythrocytic, multi-antigen, and others, and they can be administered through different routes such as intramuscular, subcutaneous, intradermal, among others. The distribution of these vaccines is facilitated through various channels, including both public and private avenues.

The malaria vaccines market research report is one of a series of new reports from The Business Research Company that provides malaria vaccines market statistics, including malaria vaccines industry global market size, regional shares, competitors with a malaria vaccines market share, detailed malaria vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the malaria vaccines industry. This malaria vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The malaria vaccines market size has grown exponentially in recent years. It will grow from $3.48 billion in 2023 to $4.7 billion in 2024 at a compound annual growth rate (CAGR) of 35.2%. The growth observed in the historic period in the field of malaria vaccines can be attributed to several factors, including the high burden of malaria, global health initiatives addressing the disease, funding and grants supporting research and development, malaria control programs, and government support and regulatory frameworks. These factors collectively contributed to advancements in the development and implementation of malaria vaccines during that period.

The malaria vaccines market size is expected to see exponential growth in the next few years. It will grow to $15.32 billion in 2028 at a compound annual growth rate (CAGR) of 34.3%. The anticipated growth in the forecast period in the field of malaria vaccines can be attributed to global efforts towards elimination goals, expanded access programs, a rise in vaccine coverage, global vaccine alliances, and the impact of climate change on the spread of malaria. Major trends expected in the forecast period include technological innovations in vaccine development, fostering public-private partnerships, promoting international collaboration, and advancements in vaccine technology. These trends are likely to shape and influence the progress and accessibility of malaria vaccines in the coming years.

The malaria vaccine market is anticipated to witness growth owing to an increase in mosquito-related diseases. These diseases, transmitted through mosquito bites, constitute a diverse range of illnesses. The RTS, S/AS01 (RTS, S) vaccine, a prominent player in the malaria vaccine market, is employed to prevent and mitigate the impact of mosquito-borne infectious diseases by training the immune system to recognize and combat the parasite. According to a November 2023 report from the World Health Organization (WHO), an estimated 249 million malaria cases occurred globally in 2022, reflecting a rise of 5 million cases from the previous year. Pakistan reported a significant increase, reaching an estimated 2.6 million cases in 2022 compared to 500,000 cases in 2021. The escalating incidence of mosquito-related diseases serves as a catalyst for the malaria vaccine market's growth.

Leading companies in the malaria vaccine market are actively innovating by developing products tailored for specific demographics, such as vaccines designed for children's malaria. This strategic approach aims to capture larger customer bases, boost sales, and augment revenue streams. Vaccines targeting mosquito-borne diseases are specialized immunological formulations offering protection against illnesses transmitted by mosquitoes. An exemplar in this category is a pediatric vaccine combating Plasmodium falciparum, the deadliest malaria parasite globally, and prevalent in Africa. In November 2022, Malawi and the World Health Organization (WHO) introduced Africa's inaugural children's malaria vaccine. The RTSS vaccine, tailored for young children, exhibits the potential to reduce mortality from the mosquito-borne disease. Despite a modest effectiveness rate of 30%, the vaccine, after pilot testing on over one million children in Ghana, Kenya, and Malawi, instills optimism for saving lives among the 400,000 individuals succumbing to malaria annually.

In August 2022, GlaxoSmithKline Plc, a prominent UK-based biopharmaceutical company, completed the acquisition of Affinivax Inc. for $3.3 billion. This strategic acquisition positions GlaxoSmithKline (GSK) to strengthen its pipeline of novel vaccines and enhance its presence in the Boston area, leveraging Affinivax Inc.'s innovative vaccine technology. Affinivax Inc., a US-based provider of vaccine technology, focuses on the development of malaria vaccines.

Major companies operating in the malaria vaccines market report are Pfizer Inc., Ipca Laboratories Ltd., Novartis AG, Sanofi SA, GlaxoSmithKline Plc., Takeda Pharmaceutical Co Ltd., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC., Lupin, Taj Pharmaceuticals Limited., Nobelpharma Co. Ltd., Bliss GVS Pharma Ltd., Sanaria Inc., Precigen Inc., AdvaCare Pharma, CellFree Sciences, Actiza Pharmaceutical Private Limited, Sumaya Biotech, VLP Therapeutics LLC, GeoVax Labs Inc., Zydus Cadila, Genvec Inc.

North America was the largest region in the malaria vaccines market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the malaria vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the malaria vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The malaria vaccines market consists of sales of circumsporozoite protein (CSP) antigens, multi-component adjuvants, and circumsporozoite protein. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Malaria Vaccines Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on malaria vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for malaria vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The malaria vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Agent: Plasmodium Falciparum; Plasmodium Vivax; Anopheles Species
  • 2) By Vaccine Type: Pre-Erythrocytic; Erythrocytic; Multi-antigen; Other Vaccines
  • 3) By Route of Administration: Intramuscular; Subcutaneous; Intradermal; Other Routes
  • 4) By Distribution Channel: Public; Private
  • Companies Mentioned: Pfizer Inc.; Ipca Laboratories Ltd.; Novartis AG; Sanofi SA; GlaxoSmithKline Plc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Malaria Vaccines Market Characteristics

3. Malaria Vaccines Market Trends And Strategies

4. Malaria Vaccines Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Malaria Vaccines Market Size and Growth

  • 5.1. Global Malaria Vaccines Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Malaria Vaccines Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Malaria Vaccines Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Malaria Vaccines Market Segmentation

  • 6.1. Global Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Plasmodium Falciparum
  • Plasmodium Vivax
  • Anopheles Species
  • 6.2. Global Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pre-Erythrocytic
  • Erythrocytic
  • Multi-antigen
  • Other Vaccines
  • 6.3. Global Malaria Vaccines Market, Segmentation By Route of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Intramuscular
  • Subcutaneous
  • Intradermal
  • Other Routes
  • 6.4. Global Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Public
  • Private

7. Malaria Vaccines Market Regional And Country Analysis

  • 7.1. Global Malaria Vaccines Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Malaria Vaccines Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Malaria Vaccines Market

  • 8.1. Asia-Pacific Malaria Vaccines Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Malaria Vaccines Market

  • 9.1. China Malaria Vaccines Market Overview
  • 9.2. China Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Malaria Vaccines Market

  • 10.1. India Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Malaria Vaccines Market

  • 11.1. Japan Malaria Vaccines Market Overview
  • 11.2. Japan Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Malaria Vaccines Market

  • 12.1. Australia Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Malaria Vaccines Market

  • 13.1. Indonesia Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Malaria Vaccines Market

  • 14.1. South Korea Malaria Vaccines Market Overview
  • 14.2. South Korea Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Malaria Vaccines Market

  • 15.1. Western Europe Malaria Vaccines Market Overview
  • 15.2. Western Europe Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Malaria Vaccines Market

  • 16.1. UK Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Malaria Vaccines Market

  • 17.1. Germany Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Malaria Vaccines Market

  • 18.1. France Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Malaria Vaccines Market

  • 19.1. Italy Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Malaria Vaccines Market

  • 20.1. Spain Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Malaria Vaccines Market

  • 21.1. Eastern Europe Malaria Vaccines Market Overview
  • 21.2. Eastern Europe Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Malaria Vaccines Market

  • 22.1. Russia Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Malaria Vaccines Market

  • 23.1. North America Malaria Vaccines Market Overview
  • 23.2. North America Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Malaria Vaccines Market

  • 24.1. USA Malaria Vaccines Market Overview
  • 24.2. USA Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Malaria Vaccines Market

  • 25.1. Canada Malaria Vaccines Market Overview
  • 25.2. Canada Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Malaria Vaccines Market

  • 26.1. South America Malaria Vaccines Market Overview
  • 26.2. South America Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Malaria Vaccines Market

  • 27.1. Brazil Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Malaria Vaccines Market

  • 28.1. Middle East Malaria Vaccines Market Overview
  • 28.2. Middle East Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Malaria Vaccines Market

  • 29.1. Africa Malaria Vaccines Market Overview
  • 29.2. Africa Malaria Vaccines Market, Segmentation By Agent, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Malaria Vaccines Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Malaria Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Malaria Vaccines Market Competitive Landscape And Company Profiles

  • 30.1. Malaria Vaccines Market Competitive Landscape
  • 30.2. Malaria Vaccines Market Company Profiles
    • 30.2.1. Pfizer Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Ipca Laboratories Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Novartis AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Sanofi SA
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. GlaxoSmithKline Plc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Malaria Vaccines Market Other Major And Innovative Companies

  • 31.1. Takeda Pharmaceutical Co Ltd.
  • 31.2. Hikma Pharmaceuticals PLC
  • 31.3. Amneal Pharmaceuticals LLC.
  • 31.4. Lupin
  • 31.5. Taj Pharmaceuticals Limited.
  • 31.6. Nobelpharma Co. Ltd.
  • 31.7. Bliss GVS Pharma Ltd.
  • 31.8. Sanaria Inc.
  • 31.9. Precigen Inc.
  • 31.10. AdvaCare Pharma
  • 31.11. CellFree Sciences
  • 31.12. Actiza Pharmaceutical Private Limited
  • 31.13. Sumaya Biotech
  • 31.14. VLP Therapeutics LLC
  • 31.15. GeoVax Labs Inc.

32. Global Malaria Vaccines Market Competitive Benchmarking

33. Global Malaria Vaccines Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Malaria Vaccines Market

35. Malaria Vaccines Market Future Outlook and Potential Analysis

  • 35.1 Malaria Vaccines Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Malaria Vaccines Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Malaria Vaccines Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer